Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Photocure

Mindre end 1K følgere

PHO

Oslo Børs

Biotechnology & Pharmaceuticals

Health Care

Oversigt
Investorkonsensus

Photocure is a medical technology company. The company specializes in photodynamic technology solutions. The solutions are used to treat diseases that cause bladder cancer and HPV. The main markets are dermatology and oncology, where the products are used by hospitals and research institutes worldwide. The company was founded in 1993 and is headquartered in Oslo, Norway.

Læs mere
Markedsværdi
-
Aktieomsætning
-
Omsætning
525,39 mio.
EBIT %
3,88 %
P/E
-
Udbytteafkast, %
-
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Selskabsmeddelelse19.11.2025, 07.00

PHO: New budget impact model study in 4 European countries concludes that BLC use offers a clinically meaningful and economically rational approach to NMIBC management

Photocure
Pressemeddelelse19.11.2025, 07.00

Photocure: New budget impact model study in 4 European countries concludes that BLC use offers a clinically meaningful and economically rational approach to NMIBC management

Photocure
Selskabsmeddelelse31.10.2025, 07.24

Photocure ASA: Notification of primary insider transaction

Photocure

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Selskabsmeddelelse31.10.2025, 07.24

Photocure ASA: Notification of primary insider transaction

Photocure
Selskabsmeddelelse29.10.2025, 06.00

Photocure ASA: Results for the third quarter of 2025

Photocure
Selskabsmeddelelse29.10.2025, 06.00

Photocure ASA: Results for the third quarter of 2025

Photocure
Selskabsmeddelelse24.10.2025, 06.20

Photocure ASA: Invitation to presentation of third quarter 2025 financial results

Photocure
Selskabsmeddelelse24.10.2025, 06.20

Photocure ASA: Invitation to presentation of third quarter 2025 financial results

Photocure
Selskabsmeddelelse15.10.2025, 15.08

PHO: Photocure and Intelligent Scopes Corporation partner on development of AI for blue light cystoscopy

Photocure
Pressemeddelelse15.10.2025, 15.08

Photocure and Intelligent Scopes Corporation partner on development of AI for blue light cystoscopy

Photocure
Selskabsmeddelelse22.9.2025, 06.23

Photocure ASA - Share option grant

Photocure
Selskabsmeddelelse22.9.2025, 06.23

Photocure ASA - Share option grant

Photocure
Selskabsmeddelelse4.8.2025, 12.39

Asieris: Cevira (APL-1702) NDA Advances to Second Round of Technical Review

Photocure
Selskabsmeddelelse4.8.2025, 12.39

Photocure: Asieris: Cevira (APL-1702) NDA Advances to Second Round of Technical Review

Photocure
Selskabsmeddelelse30.7.2025, 05.00

Photocure ASA: Results for the second quarter of 2025

Photocure
Selskabsmeddelelse30.7.2025, 05.00

Photocure ASA: Results for the second quarter of 2025

Photocure
Selskabsmeddelelse22.7.2025, 06.00

Photocure ASA: Invitation to presentation of second quarter and first half year 2025 financial results

Photocure
Selskabsmeddelelse22.7.2025, 06.00

Photocure ASA: Invitation to presentation of second quarter and first half year 2025 financial results

Photocure
Selskabsmeddelelse23.6.2025, 12.55

Photocure ASA - Share option grant

Photocure
Selskabsmeddelelse23.6.2025, 12.55

Photocure ASA - Share option grant

Photocure
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.